Immunotherapy in ovarian cancer: spatial functional genomics to unravel resistance mechanisms

Signal Transduct Target Ther. 2025 Jan 22;10(1):17. doi: 10.1038/s41392-024-02110-w.

Martina Rausch^{1

2}, Karlotta Bartels^{1

3}, Josef Leibold^{4

5}

¹ Cluster of Excellence iFIT (EXC2180) "Image-guided and Functionally Instructed Tumor Therapies" University of Tübingen, Tübingen, Germany.
² Department of Medical Oncology and Pneumology, University Hospital Tübingen, Tübingen, Germany.
³ Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany.
⁴ Cluster of Excellence iFIT (EXC2180) "Image-guided and Functionally Instructed Tumor Therapies" University of Tübingen, Tübingen, Germany. Josef.Leibold@med.uni-tuebingen.de.
⁵ Department of Medical Oncology and Pneumology, University Hospital Tübingen, Tübingen, Germany. Josef.Leibold@med.uni-tuebingen.de.

No abstract available

Grants and funding